In addition to cancer, the SLC22A3-LPAL2-LPA gene cluster was also previously identified in a genome-wide association (GWAS) haplotype study as a risk locus for coronary artery disease (CAD) [14]. This evidence concerns the gene LPAL2 and coronary artery disorder.